[HTML][HTML] The how's and what's of vaccine reactogenicity

C Hervé, B Laupèze, G Del Giudice, AM Didierlaurent… - npj Vaccines, 2019 - nature.com
Reactogenicity represents the physical manifestation of the inflammatory response to
vaccination, and can include injection-site pain, redness, swelling or induration at the …

[HTML][HTML] Toward precision adjuvants: optimizing science and safety

E Nanishi, DJ Dowling, O Levy - Current opinion in pediatrics, 2020 - journals.lww.com
Toward precision adjuvants: optimizing science and safety : Current Opinion in Pediatrics
Toward precision adjuvants: optimizing science and safety : Current Opinion in Pediatrics Log …

[HTML][HTML] Review of COVID-19 vaccines and their evidence in older adults

SP Teo - Annals of geriatric medicine and research, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant …

[图书][B] Uncertainty: How it makes science advance

K Kampourakis, K McCain - 2019 - books.google.com
Scientific knowledge is the most solid and robust kind of knowledge that humans have
because of the self-correcting character inherent in its own processes. Nevertheless, anti …

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations

SG Sullivan, OH Price… - Therapeutic advances in …, 2019 - journals.sagepub.com
Vaccination is the most practical means available for preventing influenza. Influenza
vaccines require frequent updates to keep pace with antigenic drift of the virus, and the …

[HTML][HTML] Potentials of saponins-based adjuvants for nasal vaccines

K Chen, N Wang, X Zhang, M Wang, Y Liu… - Frontiers in …, 2023 - frontiersin.org
Respiratory infections are a major public health concern caused by pathogens that colonize
and invade the respiratory mucosal surface. Nasal vaccines have the advantage of …

Precision vaccine adjuvants for older adults: a scoping review

E Nanishi, A Angelidou, C Rotman… - Clinical Infectious …, 2022 - academic.oup.com
Older adults, defined as those≥ 60 years of age, are a growing population vulnerable to
infections including severe acute respiratory syndrome coronavirus 2. Although …

[HTML][HTML] Challenges for clinical development of vaccines for prevention of hospital-acquired bacterial infections

I Bekeredjian-Ding - Frontiers in immunology, 2020 - frontiersin.org
Increasing antibiotic resistance in bacteria causing endogenous infections has entailed a
need for innovative approaches to therapy and prophylaxis of these infections and raised a …

Vaccination of adults in general medical practice

P Hunter, SA Fryhofer, PG Szilagyi - Mayo Clinic Proceedings, 2020 - Elsevier
In vaccinating adults, clinicians face 2 types of challenges:(1) staying current on
recommendations for influenza, pneumococcal, hepatitis A and B, zoster, and other vaccines …

Headache after COVID-19 vaccination: updated report from the Italian Medicines Agency database

C Mattiuzzi, G Lippi - Neurological Sciences, 2021 - Springer
Recent evidence suggests that headache is common in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections [1]. Although universal vaccination appears the …